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1. Introduction 
For two decades, FMS was diagnosed based on the criteria established on 1990 by the 
American College of Rheumatology, i.e. by the identification of widespread pain of at least 3 
months duration, and pain and tenderness evoked by palpation in at least 11 of 18 specific 
bodily sites (Wolfe et al., 1990). Recently, the ACR preliminary diagnostic recommendations 
for fibromyalgia abandoned the tender point examination criterion, and were established as 
the following 3 conditions: (i) Widespread Pain Index (WPI) equal to or greater than 7 and 
Symptom Severity Score (SS) equal to or greater than 5, or WPI ranging between 3 and 6 and 
the SS equal to or greater than 9; (ii) steady presence of symptoms for at least 3 months; and 
(iii) the absence of a disorder that would otherwise explain the pain.  
Despite being highly prevalent, the etiology and pathophysiology of FMS remains obscure. 
Diverse factors contributing to this condition have so far been identified, however none has 
been proven unequivocally responsible. Due to limited understanding of the etiology  
and pathophysiology of FMS, a diversity of pharmacological and nonpharmacological 
interventions alone and in combination have been attempted to treat the symptoms, largely 
on a trial-and-error basis. However, this condition remains largely refractory to treatment.  
1.1 Overcoming clinical heterogeneity by subgrouping patients 
Clinical variability within individuals whose disease manifestations meet the ACR criteria is 
enormous. While chronic pain represents a clinical manifestation that all FMS patients share 
in common, pain may be largely the only symptom experienced by some individuals with 
FMS while others present with a myriad of psychological manifestations, and even other 
disease entities such as chronic fatigue syndrome, irritable bowel syndrome or 
temporomandibular dysfunction also are frequently found in patients with FMS (Aaron & 
Buchwald, 2001).  
Because of this heterogeneity of symptoms, authors have suggested that there is a need for 
empirically derived subgroups. These subgroups should not only be based on easily 
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measurable variables but also clinically relevant in assisting to target more specific 
therapeutic interventions to individuals (Bennett et al., 1991; Masi & Yunus, 1991; Turk et 
al., 1996). Indeed, there is a growing awareness regarding the need to identify subgroups of 
chronic pain patients on the basis of biological and psychosocial characteristics, as a strategy 
to overcome some of the problems derived from patient heterogeneity. On the one hand, if 
one assumes patient homogeneity and relies on measuring group means to assess treatment 
outcome, false negative outcomes may be magnified. Specificity should thus be optimized 
by interventions in patient subgroups characterized by operating pathogenic vectors, and 
intervention outcome may be more specifically assessed if targeted at homogeneous patient 
subpopulations even when underlying mechanisms are not well understood. On the other 
hand, assuming patient homogeneity when prescribing treatment will not provide relief or 
amelioration of symptoms for a significant proportion of patients, and subsets of patients 
may be receiving treatment for symptoms without necessity.  
In chronic pain patients, numerous studies have attempted to respond to this need for 
patient subgrouping by empirically identifying patient subsets based on psychological 
characteristics and psychopathology. Turk and collaborators (1996) were among the first to 
identify chronic pain patients subgroups by using cluster analysis techniques, based on the 
Multidimensional Pain Inventory. Importantly, FMS patients classified into different 
subgroups according to those criteria may respond differently to treatment (Turk et al., 
1998). FMS patients have also been classified empirically on the basis of psychopathological 
profiles by using the 90 Symptoms Checklist (SCL-90) (Williams et al., 1995). Indeed, a 
growing literature has suggested that psychological mechanisms may be important 
correlates in the establishment and maintenance of FMS (Boissevain & McCain 1991), and 
previous observations have shown that certain psychological variables, in combination with 
pain sensitivity indices, may best distinguish FMS patient subsets (Giesecke et al., 2003).  
There have been several other attempts or proposals. Müller and collaborators (2007) 
proposed that FMS may be categorized as primary or secondary. According to the authors, 
primary fibromyalgia may be much more common than the secondary type and is 
characterized by the absence of any definitive organic factor triggering the syndrome, 
whereas in secondary fibromyalgia the underlying disease, such as inflammatory rheumatic 
processes or collagenosis can be easily diagnosed. Based on clinical manifestations, they 
defined four subtypes of patients with primary fibromyalgia that may reportedly benefit 
from different treatment strategies. Patients with fibromyalgia with extreme sensitivity to 
pain but with no associated psychiatric conditions would be best treated by administration 
of the 5-HT3 receptor-antagonist tropisetron, whereas patients with fibromyalgia and 
comorbid, pain-related depression, or patients with depression with concomitant 
fibromyalgia syndrome would both ideally benefit from treatment with antidepressants. 
Finally, the focus of treatment should be on psychotherapy in the fourth group, which was 
composed of patients with fibromyalgia due to somatization (Müller et al., 2007). In 
secondary fibromyalgia, the initial focus should be on influencing the underlying disease, 
and for example a regimen of daily administration of 5 mg tropisetron for 5 days was found 
by these authors to be as effective in fibromyalgia patients whose pain was not relieved by 
non-steroidal analgesics, as in patients suffering from associated progressive scleroderma or 
other collagen-related diseases (Müller et al., 2007).  
In one-hundred fifteen patients with FMS, Thieme and co-workers (2004) assessed mental 
status by using the DSM-IV, as well as pain, impact of pain, anxiety and depression, 
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posttraumatic stress disorder-like symptoms, and sexual and physical abuse. Based on the 
Structured Clinical Interview for DSM-IV, axis I disorders were grouped into (i) anxiety and 
(ii) mood disorders, the latter including major depressive episode, major depressive 
disorder, and dysthymic disorder. The authors conducted a multivariate analysis of 
variance (MANOVA) to assess differences among the groups with no axis I disorders, 
anxiety disorders, and mood disorders, and one-way ANOVAs were conducted following a 
significant MANOVA. Their analysis yielded three psychosocial subgroups that were 
termed Dysfunctional, Interpersonally Distressed, and Adaptive Copers. The Dysfunctional 
and Interpersonally Distressed groups mainly reported anxiety and mood disorders, 
respectively, while the Adaptive Copers group exhibited little comorbidity. These findings 
were further suggestive that, rather than being a homogeneous diagnosis, varying 
proportions of FMS patients present with comorbid anxiety and depression dependent on 
psychosocial characteristics, emphasizing the importance of assessing patients with FMS for 
the presence of affective distress and not treating them as a homogeneous group. A recent, 
additional attempt to identify FMS patient subgroups was that advanced by Hasset and co-
workers (2008). These authors proposed a classification based on affect balance styles, which 
considered four categories, including (i) healthy subjects with high levels of positive affects 
(PA) and low levels of negative affect (NA), (ii) low (low PA/low NA), reactive (high 
PA/high NA), and depressive (low PA/high NA). The authors found high prevalence of 
depressive and reactive affect balance styles in patients with FMS, and reported an 
association between affect balance style and psychiatric comorbidity.  
Giesecke and co-workers (2003) proposed a classification scheme based on variables from 
three clinical domains, namely pain sensitivity and hyperalgesia, cognitive variables 
including coping strategies and catastrophizing, as well as mood and negative affective 
states such as depression and anxiety. They assessed pressure pain sensitivity by the use of 
an algometer, whereas cognitive evaluation was largely conducted by means of the Coping 
Strategies Questionnaire and psychological distress was assessed by using the Center for 
Epidemiologic Studies Depression Scale and the State-Trait Personality Inventory. By using 
agglomerative hierarchic cluster analysis and multiple analyses of variance to confirm that 
each variable used in the analysis was differentiated by the cluster solution, these authors 
claimed the existence of three clinical profiles that were distinctly different in terms of 
anxiety, depression, catastrophizing, control over pain and pressure-pain sensitivity. One 
subgroup of patients  was distinguished by moderate mood scores, moderate levels of 
catastrophizing and perceived control over pain, and low levels of pain sensitivity. A second 
subgroup  exhibited poorer mood scores, highest scores on the catastrophizing subscale, the 
lowest values for perceived control over pain, and high levels of tenderness. The third group 
 displayed normal mood, very low levels of catastrophizing, high perceived control over 
pain, but increased pain sensitivity. 
More recently, de Souza and collaborators (de Souza et al., 2009) relayed on hierarchical 
clustering analysis techniques of selected items of the Fibromyalgia Impact Questionnaire 
(FIQ), a self-administered report that comprehensively reflects the functional capacity and 
the occurrence and severity of typical symptoms of the disease (Burckhardt et al., 1991). 
These authors proposed a two-cluster group solution based on differences in scores on 
specific items of the FIQ, where so termed type II subjects reported higher scores on anxiety, 
depression and morning tiredness items over type I subjects (de Souza et al., 2009). A major 
strength of this classification scheme is that it assesses the most prevalent complaints 
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reported by persons with FMS while being easy to administer in the clinical setting. These 
two subgroups scored differently on Pain Catastrophyzing Scale scores, Interference and 
Life Control subscales of the Multidimensional Pain Inventory, or the SF-36 mental 
component summary. This classification scheme highlighted the contribution of emotional 
status to clinical variability in FMS patients and provided an avenue for refining treatment 
by addressing psychological comorbidities in discrete subpopulations. Observations by de 
Souza’s group have been replicated in a larger sample, and differences in depressive and 
anxiety symptoms have been corroborated by using the Beck Depression Inventory and the 
Hospital Anxiety and Depression Scale, respectively (Calandre et al., 2010).  
Although depression and anxiety have been extensively studied in persons with FMS, also 
general psychopathology is prevalent in fibromyalgia relative to other chronic conditions 
(Epstein et al., 1999; Gormsen et al., 2010; Shaver et al., 1997), acute disorders (Gatchel, 1996) 
or asymptomatic subjects (Arnold et al., 2008; Dersh et al., 2002; Hellström & Jansson, 2001; 
Winfield, 2000) and, for example, post-traumatic stress disorder may affect 50% of subjects 
suffering from FMS (Fietta et al., 2007), whereas obsession, somatization disorders and 
alexithymia are reportedly present in up to 55%, 71%, and 47%, respectively (Centonze et al., 
2004). High prevalence of positive testing for bipolar disorder among patients with FMS has 
also recently been reported (Wilke et al., 2010).  
1.2 Does the McGill Pain Questionnaire capture clinically relevant information? 
Verbal rating scales are among the most commonly used methods for assessing pain 
intensity. Due to the ease with which they can be administered and because they are 
generally easy to comprehend, compliance rates for verbal rating scales are comparable to 
those obtained for other measures of pain intensity (Jensen et al., 1986, 1989). In addition, 
verbal rating scales are positively co-related to other measures of pain intensity and are 
sensitive tools to assess treatment outcome (Fox & Melzack, 1976; Ohnhaus & Adler, 1975; 
Rybstein-Blinchik, 1979), and thus can be considered as valid indicants of pain intensity 
(Ahles et al., 1984; Downie et al., 1978; Jensen et al., 1986, 1989;  Kremer et al., 1981; Littman 
et al., 1985; Ohnhaus & Adler, 1975; Woodforde & Merskey, 1972).  
The McGill Pain Questionnaire (MPQ) (Chen & Treede, 1985; Dubuisson & Melzack, 1976; 
Melzack, 1975, 1985) is a widely employed verbal pain assessment tool. The MPQ comprises 
20 subscales or sets of verbal descriptors designed to evaluate the sensory, affective, 
evaluative and miscellaneous dimensions of pain.  
A number of studies have shown that the MPQ can capture clinical characteristics of pain 
that predict the occurrence of distinct underlying pathogenic mechanisms. For example, 
Gruschka and Sessle (1984) administered the MPQ to 102 patients presenting with 
toothache, in order to test the sensitivity of this tool to distinguish between dental pain 
originating from reversible or irreversible tooth pulp inflammation. In that study, patients 
suffering from pain derived from necrotic or irreversibly inflamed tooth pulp scored 
significantly higher on the total Pain Rank Index, as well as on the sensory, evaluative and 
miscellaneous Pain Rank Indices, although no differences were found as to the affective-
motivational dimension, in such a manner that the MPQ alone was capable of predicting 
diagnosis in 73% of patients. Melzack and co-workers (1986) used a similar approach to 
distinguish between trigeminal neuralgia and atypical facial pain patients, and they were 
able to correctly classify 91% of the patients based on 7 descriptors of the MPQ.  
In the present study, we hypothesized that the MPQ might indeed be capable of capturing 
distinctive pain characteristics in homogeneous subgroups of patients with FMS. However, 
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understanding complex relationships between subjects across multiple variables may be 
difficult, and in particular the MPQ comprises a considerable number of items to address 
several dimensions of the complex experience of pain. Data visualization techniques attempt 
to solve these difficulties by transforming high-dimensional data into lower dimensional 
topologies that may be better understood visually. A relatively novel approach to discover 
similarity relations between data objects in high-dimensional signal space is the Self-
Organizing Maps (SOMs), a relatively recent methodology for unsupervised machine 
learning. A SOM is an artificial intelligence technique, first introduced by Teuvo Kohonen 
(1995), that is commonly used to non-linearly project multidimensional input data into a bi-
dimensional output space, thus providing the investigator with a visual image of the data 
that better depicts their structure and relationships. A simple SOM layout typically consists 
of an input neuron layer, a competition layer and an output layer. The SOM builds a two-
dimensional regular lattice where the location of a map unit, or neuron, is indicative of 
relative distances between data points in the high-dimensional space, in such a way that 
mapping or data structure from the high-dimensional space onto map units are preserved. 
Based on this property, the SOM can serve as a very efficient, powerful and highly visual 
tool for cluster analysis of high-dimensional data (Kohonen, 1995). This has been the 
selected use for the SOM in the present work. The SOM algorithm, also known as the 
Kohonen feature map algorithm, is a well known artificial neural network algorithm that is 
based on unsupervised learning, in contrast to many other neural networks using 
supervised learning. 
2. Methods 
2.1 Setting and data collection 
A total of 30 consecutive FMS subjects (28 females, 2 males) aged 29-82 years (58±10.38) 
participated in the study. Subjects were recruited through advertisements, FMS associations 
and informative presentations. All participating subjects had been diagnosed with FMS on 
according to the 1990 ACR classification criteria at least one year prior to the initiation of 
this study. The study was approved by the Ethical Review Board of the University of the 
Basque Country, and all participants provided their written, informed consent.  
Subjects were interviewed individually by a trained psychologist. Sociodemographic data 
were collected first, and self-applied questionnaires were then administered for clinical 
assessment in the same session, including the MPQ, FIQ, Medical Outcomes Study – Short 
Form 36 (SF-36) and SCL-90-R (c.f. below). Participants were not asked to discontinue 
medication prior to study.  
We used the validated Spanish translation of the MPQ (Lázaro et al., 1994), which includes a 
total of 78 descriptors of pain. In this version, five out of the 78 descriptors are computed 
into a Present Pain Index (PPI) measuring overall pain intensity. A zero score was assigned 
here if no descriptor was chosen. PRIs on sensory, affective-motivational, evaluative and 
miscellaneous dimensions of pain were obtained from weighted MPQ item scores. A total, 
cumulative PRI was also calculated. Subjects were also asked to assess the level of pain 
using the Visual Analog Scale (VAS), that is, by placing a mark on a line 10 cm long at an 
appropriate distance between two endpoints signaling no pain at all and the most intense 
pain imaginable (Huskisson, 1974; Scott & Huskisson, 1976).  
The Fibromyalgia Impact Questionnaire (FIQ) is a 20-term, self-administered questionnaire 
that assesses both psychological and physical symptoms of FMS and allows for a broad 
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quantification of interference of the condition on daily living tasks and quality of life 
(Burckhardt et al., 1991). It is quickly administered and easily evaluates a broad range of 
clinical characteristics associated to FMS. The total FIQ score can adopt values ranging from 
0 to 10, where higher scores denote greater severity or impact. The FIQ is held to be a 
sensitive tool to monitor progression of the FMS and response to treatment in clinical trials 
(Dunkl et al., 2000). We used the Spanish language version validated by Monterde and co-
workers (2004).  
The Spanish version of the SF-36 (Alonso et al., 1995) was administered to assess overall 
health status. The physical component summary (PCS) and the mental component summary 
(MCS), whose values can range from 0 to 100 where higher values relate to better quality of 
life, were calculated.  
The 90 Symptom Checklist Revised (SCL-90-R) (Derogatis, 1994) is a self-reported inventory 
that inquiries patients on the level of distress generated by 90 hypothetical situations, and 
provides scores on 9 psychopathological dimensions, namely somatization, obsessive-
compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, 
paranoid ideation and psychoticism, plus additional scores assessing the severity of the 
above dimensions. SCL-90-R has proved useful for assessing emotional status in chronic 
pain patients, since it is an inexpensive way to access a significant amount of data on a range 
of psychopathological dimensions (Torres et al., 2010). Here, we used the validated version 
for Spanish language (González de Rivera et al., 2002). For each subscale, composite 
normalized T-scores with a mean of 50 and standard deviation of 10 were obtained on the 
basis of standardized norms for nonpsychiatric patients provided in the test manual 
(González de Rivera et al., 2002). The global severity index (GSI), positive symptom total 
(PST) and positive symptom distress index (PSDI) were also obtained.  
2.2 Analysis with Self-Organizing Maps 
Raw scores from all 20 MPQ items were normalized prior to SOM analysis, and scores from 
items contributing to the four studied subscales were fed to separate SOMs. Geometry of the 
two-dimensional SOMs was set to 10 rows x 20 columns, and the grid of the SOM units was 
selected as hexagonal from the beginning. Competition layer neurons were initialized 
randomly as a pre-processing step, and the SOM was then trained by iteratively calculating 
similarity measures as Euclidean distances.  
The unified distance matrix (U matrix) method is the most commonly used method to 
render the SOM. The U matrix consists of a regular neuron grid where each cell or node 
represents a neuron, and distances between neighboring neurons provide a bi-dimensional 
representation of the distance of the corresponding reference vectors. The basic idea of this 
method is based on the principle of representing the distance matrix between the all the 
reference vectors associated to the SOM units by using colorings or shades of gray, where a 
dark shade of gray between neurons denotes a large distance and thus a gap between the 
vectors in the input space, whereas light shades represent close relationships between 
neighboring units. Analogously, light areas in a U matrix can be seen as a representation of 
clusters whereas dark areas denote cluster separators. Thus a U matrix representation of a 
SOM can be a practical way to easily visualize clusters in the input space when no a priori 
information exists on the input data. Here, U matrices yielded by the four maps were used 
to decide on the presence of patient clusters on each analyzed MPQ dimension and the 
convenience of further statistical analyses.  
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2.3 Characterization of FMS patient subpopulations 
Subjects located on each side of a cluster separator were considered as belonging to separate 
clusters. Subsequently, the resulting patient clusters were compared as to a number of 
clinical and psychological determinants, in order to verify the capability of the SOM analysis 
to discriminate between clinically distinct patient subpopulations. Firstly, we wished to 
know whether FMS patient subgroups discriminated by the SOM analysis on the basis of 
their scoring profiles on a given pain dimension also exhibited differential profiles on other 
dimensions of pain or differences in intensity of experienced pain. Secondly, we compared 
identified patient clusters in terms of severity of the disease and impact on health-related 
quality of life. Finally, we assessed whether or not patients with FMS belonging to different 
clusters also differed in associated psychological comorbidity.  
3. Results 
We used self-organizing maps to test whether verbal pain descriptors on the MPQ that 
address sensory, affective-motivational and evaluative dimensions of pain would be able to 
discriminate between clinically distinct FMS patients.  
 
 
Fig. 1. U-matrix representation of responses from patients with FMS on MPQ items 
addressing the affective-motivational dimension of pain. Neurons of the network are 
marked as dots, whereas open circles indicate neurons representing patients with FMS. The 
cluster separating zone, represented here by the dark gap, segregates two patient subgroups 
which are termed here as cluster 1 (right side of the map) and cluster 2 (left side). 
SOM analysis of the MPQ items corresponding to the sensory, evaluative and miscellaneous 
domains of the test failed to suggest the existence of clinically distinct patient subsets. 
Therefore, no further analysis was conducted on these dimensions. However, SOM analysis 
of the responses to items 15 through 17, i.e. those addressing the affective-motivational 
domain of pain, consistently revealed the existence of two distinct subject clusters (figure 1), 
which will be referred to as cluster 1 and cluster 2 hereafter.  
Cluster 1 comprised 17 out of the 30 subjects of the sample, whereas 13 subjects were found 
to fall within cluster 2. General characteristics of both clusters are provided in table 1. No 
statistically significant differences were found between clusters with respect to age, gender, 
years since diagnosis, or active status. The two FMS patient clusters were indistinguishable 
in terms of MPQ scores on sensory-discriminative, evaluative and miscellaneous 
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dimensional scores (table 2). As well, no significant between-clusters differences were found 
as to Present Pain Index scores or intensity of pain as measured by the VAS. 
 
 cluster 1 
n=13 
cluster 2 
n=17 
Mean age (s.d.) 51.85 (7.76) 50.35 (12.21) (1) 
Women (%) 100 88.2 (2) 
Mean years from diagnosis 4.76 (1.32) 3.94 (0.95) (1) 
Active status 23.2% 41,2% (2) 
Table 1. Sociodemographics of patients with FMS classed as cluster 1 and cluster 2. 
Differences between groups were not significant ((1) Student’s t test; (2) Mann-Whitney U test). 
 
 cluster 1 cluster 2 
McGill Pain Questionnaire   
Sensory PRI 21.00 ±4.912 22.15 ±4.298 
Affective-motivational PRI 4.41 ±1.906 6.08 ±1.935 * 
Evaluative PRI 7.71 ±2.054 7.85 ±2.267 
Miscellaneous PRI 3.24 ±0.903 3.46 ±0.660 
Total PRI 36.35 ±8.299 39.54 ±5.348 
Number of words 14.00 ±1.852 16.54 ±1.450 ** 
PPI 2.82 ±0.809 3.08 ±1.038 
Pain intensity (VAS) 6.76 ±1.15 7.05 ±0.92 
Total FIQ score 6.83 ±1.296 7,90 ±1.277 * 
SF-36   
Physical component Summary 39.81±9.206 29.77±7.224 ** 
Mental component Summary 50.60±25.436 22.22±9.149 ** 
Table 2. Summary of measures of pain and assessment of clinical status in FMS patient 
clusters. * p<0.05 and ** p<0.01 as compared to cluster 1.  
Not surprisingly, the two subpopulations segregated by SOM analysis on the basis of affective 
dimensional scoring profiles differed significantly (p<0.05 at the Student's t test) in their 
affective Pain Rating Index (table 2). Specifically, cluster 1 patients exhibited lower scores (4.41 
±1.906) that cluster 2 patients (6.08 ±1.935). In addition, the total number of words chosen by 
cluster 1 patients was significantly lower (14.00 ±1.852) than cluster 2 patients (16.54 ±1.450).  
Clinical status in both patient clusters was assessed here by using the FIQ and the SF-36. 
Cluster 2 patients exhibited significantly more severe FMS in terms of total FIQ scores 
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(7,90±1.277) as compared to cluster 1 patients (6.83±1.296, p<0.05 at the Student's t test). 
Health-related quality of life was also significantly poorer in cluster 2 patients as assessed by 
the physical component summary (29.77±7.224) and the mental component summary 
(22.22±9.149) derived from the SF-36 items, relative to cluster 1 patients (39.81±9.206 and 
50.60±25.436, respectively.  
Psychological status was assessed by means of the SCL-90-R. The profile exhibited by FMS 
patients classed as cluster 1 was fully within normal levels for nonpsychiatric population 
(figure 2). In contrast, subjects in cluster 2 exhibited generally higher levels of 
psychopathology. Composite normalized T-scores in these patients were significantly higher 
and well above the diagnostic cutoff value of 60 on dimensions somatization, obsession-
compulsion, depression, anxiety, paranoia, and psychoticism. On the global severity index 
(GSI), positive symptom total (PST) and positive symptom distress index (PSDI), cluster 2 
patients also scored above the diagnostic level, although differences with respect to cluster 1 
scores were not statistically significant.  
 
 
Fig. 2. Psychological profiles based on composite, normalized T-scores of the SCL-90-R in 
the two FMS patient clusters identified by SOM analysis. Scores of cluster 2 patients are 
generally higher and above diagnostic level on subscales somatization, obsession-
compulsion, depression, anxiety, paranoia, and psychoticism.  
4. Discussion 
4.1 What is in the affective-motivational dimension of pain?  
Pain descriptors have long been analyzed to differentiate medical from psychiatric 
diagnoses or to differentiate among medical diagnostic categories. Back in the 70's, Veilleux 
and Melzack (1976) proposed that the pattern of sensory and affective pain descriptors used 
by patients may be clinically useful, since patients with persisting pain complaint within a 
psychiatric population used more sensory than affective descriptors to describe their pain, 
whereas patients with rather transient pain used more affective than sensory descriptors. 
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These investigators suggested that a pattern dominated by sensory descriptors may indicate 
traditional methods of pain control, whereas psychiatric approaches may be more 
appropriate when affective descriptors prevail (Veilleux & Melzack, 1976).  
Pain affect can be defined as the emotional arousal and disruption engendered by the pain 
experience. Arousal produced by pain, which may be experienced as frightening or 
distressing, can interfere in daily activities and habitual modes of response. Measures of 
pain affect can be complex and heterogeneous, and can be different from measures of pain 
intensity (Gracely, 1992; Jensen et al., 1989). In a sense, pain may not be different from other 
sensory-perceptual experiences in that, in the same way that identifying a pitch or a melody 
can be distinguished from what that sound means to us or how it makes us feel, pain 
intensity or location may be considered as different from its affective or motivational 
interpretation. The emotional response to pain is closely related to the meaning the patient 
gives to the pain experience. Hence, pain is likely to engender more suffering when it is 
perceived as indicative of threat to the subject's physical, psychological, or social integrity 
than when it is not considered to be a threat. It is thus not hard to understand that among 
cancer patients, the emotional aspects of pain can eventually come to dominate the whole 
clinical picture. According to their affective dimensional scores, cluster 2 FMS patients as 
characterized here are thus likely to associate negative affect to their perception of pain and 
disease.  
The Affective subscale of the McGill Pain Questionnaire (MPQ) is by far the most widely 
used measure of pain affect. The results of the present study demonstrate that segregation of 
patients with FMS on the basis of the affective-motivational dimension of pain results in 
reliable segregation on other indicators of physical and psychological status. Patients 
classed as cluster 2, which exhibited higher scores on the pain affect scale, also reported 
poorer clinical status as revealed by the FIQ and the MCS and PCS, and showed 
psychological comorbidities in a number of subscales addressed by the SCL-90-R. In 
contrast, patients of cluster 1 showed no psychological distress and lower levels of 
severity of disease. A reasonable interpretation of this finding is that the affective 
dimension of the MPQ provides a good indication of psychological distress and mood 
disturbances associated to FMS. In connection with this, it may be argued that, since 
mood is known to modulate perceived pain intensity (Von Graffenried et al., 1998), higher 
scores on the affective dimension could be considered to indicate the contribution of pain 
affect to perceived pain intensity. However, we failed to find significant differences 
between clusters as to sensory-perceptual or evaluative dimensions of pain and intensity 
of pain as measured by the VAS. This appears to suggest that psychological factors may 
be influencing the clinical status of patients with FMS irrespective of sensory aspects and 
intensity of pain. As a consequence, interventions addressing associated psychopathology 
might be expected to improve FMS and health-related quality of life without necessarily 
alleviating the perceived levels of pain.  
4.2 Clues to therapeutic intervention 
It is reasonable to assume that treatment can be enhanced if it is appropriately tailored to the 
patient characteristics and that therapeutic interventions targeted at specific needs identified 
in patient subgroups should be substantially more effective than therapies prescribed just by 
matching to medical diagnosis. This is why research into the heterogeneity and individual 
variability in patients with FMS is of such great importance, as is the identification of 
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distinctive features of relevant patient subgroups. The clinical practice should also respect 
this heterogeneity and should aim at developing interventions that best match the needs of 
the individual patient. There has been a growing awareness of the importance of 
psychological factors in reports of pain (Gatchel & Turk, 1999). For example, physical factors 
fail to predict pain severity or life interference in patients with low back pain or rheumatoid 
arthritis, whereas assessment of helplessness and hopelessness can help to predict reported 
pain and behavior in response to pain (Flor & Turk, 1988). In addition, variables other than 
medical diagnoses and identified physical pathology may affect treatment outcome (Jensen 
et al., 1994, 2001). In particular, perceptions of control over pain is inversely correlated with 
pain, depression, and physical disability, whereas catastrophizing and beliefs about being 
disabled may be directly associated.  
It has long been suggested that high affective scores indicate the necessity of a 
psychotherapeutic approach (Veilleux & Melzack, 1976). Psychotherapy appears to be 
mandatory in subgroups of patients displaying measurable distortions of pain affect. An 
implication of the present results is that only one subset of patients with FMS, namely the 
one termed here as cluster 2, is likely to benefit from a psychotherapeutic intervention. Thus, 
in these patients, criteria used to tailor psychotherapeutic interventions may allow for 
different factors in a biopsychosocial model (Keefe et al., 2004). Treatment tailored to the 
shared cognitive behavioral factors may enhance treatment effects (Prins et al., 2001; 
Bazelmans et al., 2006). Indeed, in patients with chronic pain, treatment outcomes tend to be 
affected by specific cognitive behavioral factors such as passive pain coping and 
helplessness (Nicassio et al., 1995; Rollman & Lautenbacher, 1993). Cognitive-behavioral 
therapies can successfully modify key elements of the fear-avoidance model in patients with 
chronic low-back pain (de Jong et al., 2005; Vlaeyen et al., 2001, 2002). Likewise, factors 
shared in common by specific FMS patients subsets should be taken into account. For 
example, approaches aimed at pain acceptance that proved relevant in chronic pain should 
be considered for FMS (Evers et al., 2001; McCracken et al., 2005). Meta-analyses have 
concluded that cognitive-behavioral therapy in combination with physical exercise training 
is the most effective non-pharmacological treatment for FMS (Goldenberg et al., 2004; 
Hadhazy et al., 2000; Rossy et al., 1999; Sim & Adams, 2000). Behavioral reactions such as 
avoidance, cognitive reactions including increased attention to bodily sensations and 
catastrophizing, and physiological reactions such as increased neurovegetative arousal and 
muscle tension, all are appropriate adaptive short-term reactions. However, they may 
become detrimental in the long term in response to chronic pain (Evers et al., 2001; Flor & 
Birbaumer, 1990; Turk & Flor, 1999). For example, muscle tension and neurovegetative 
hyperactivity, which are physiological reactions to pain, may lead to higher levels of pain 
and functional disability in the long term if misinterpreted as evidence of physical harm 
(Bortz, 1984; Flor & Birbaumer, 1990). Catastrophizing is also an important cognitive factor 
in chronic pain (McCracken & Gross, 1993; Vlaeyen et al., 1995). Exaggeration of negative 
interpretations of pain may lead to increased levels of pain-related fear, and this may in turn 
result in increased attention to bodily sensations and hypervigilance to pain (McCracken, 
1997). Finally, sustained avoidance of physical activities can worsen musculoskeletal 
condition, thereby contributing to exacerbate pain (Bortz, 1984). On this basis, a number of 
treatments have been aimed at modifying the patient’s pain experience and disability. 
Although studies show that the cognitive-behavioral approach alone does not generally 
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provide significant benefits to FMS patients over group educational or physical exercise 
programs, it may indeed be beneficial for patients in great psychological distress (Van Koulil 
et al., 2007).  
5. Conclusions 
The results of this pilot study based on SOM analysis suggest that the affective-motivational 
domain of the MPQ discriminates between two FMS patient subpopulations with distinctly 
different levels of illness severity and associated psychopathology. According to these 
findings, psychotherapeutic intervention on one subset of patients with FMS with associated 
psychopathology may result in better clinical status and improved quality of life.  
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